Exact Mass: 392.1729
Exact Mass Matches: 392.1729
Found 277 metabolites which its exact mass value is equals to given mass value 392.1729
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sparfloxacin
Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. DNA gyrase is an essential enzyme which controls DNA topology and assists in DNA replication, repair, deactivation, and transcription. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Dovitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
O-Desmethylcarvedilol
O-Desmethylcarvedilol is only found in individuals that have used or taken Carvedilol. O-Desmethylcarvedilol is a metabolite of Carvedilol. O-desmethylcarvedilol belongs to the family of Carbazoles. These are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring.
4-[2-[5,5-Dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid
Dovitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Mardepodect
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
2-[1-[(2S)-2-[[4-[(E)-N'-Hydroxycarbamimidoyl]benzoyl]amino]propanoyl]piperidin-4-yl]oxyacetic acid
1-benzo[1,3]dioxol-5-ylmethyl-6-methoxy-4-((S)-1-methyl-pyrrolidin-2-yl)-isoquinolin-7-ol|Arenin|Arenine
Sparfloxacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Ala Ala Met Thr
Ala Ala Thr Met
Ala Cys Ile Ser
Ala Cys Leu Ser
Ala Cys Ser Ile
Ala Cys Ser Leu
Ala Cys Thr Val
Ala Cys Val Thr
Ala Ile Cys Ser
Ala Ile Ser Cys
Ala Leu Cys Ser
Ala Leu Ser Cys
Ala Met Ala Thr
Ala Met Thr Ala
Ala Ser Cys Ile
Ala Ser Cys Leu
Ala Ser Ile Cys
Ala Ser Leu Cys
Ala Thr Ala Met
Ala Thr Cys Val
Ala Thr Met Ala
Ala Thr Val Cys
Ala Val Cys Thr
Ala Val Thr Cys
Cys Ala Ile Ser
Cys Ala Leu Ser
Cys Ala Ser Ile
Cys Ala Ser Leu
Cys Ala Thr Val
Cys Ala Val Thr
Cys Gly Ile Thr
Cys Gly Leu Thr
Cys Gly Thr Ile
Cys Gly Thr Leu
Cys Ile Ala Ser
Cys Ile Gly Thr
Cys Ile Ser Ala
Cys Ile Thr Gly
Cys Leu Ala Ser
Cys Leu Gly Thr
Cys Leu Ser Ala
Cys Leu Thr Gly
Cys Ser Ala Ile
Cys Ser Ala Leu
Cys Ser Ile Ala
Cys Ser Leu Ala
Cys Thr Ala Val
Cys Thr Gly Ile
Cys Thr Gly Leu
Cys Thr Ile Gly
Cys Thr Leu Gly
Cys Thr Val Ala
Cys Val Ala Thr
Cys Val Thr Ala
Gly Cys Ile Thr
Gly Cys Leu Thr
Gly Cys Thr Ile
Gly Cys Thr Leu
Gly Gly Pro Tyr
Gly Gly Tyr Pro
Gly Ile Cys Thr
Gly Ile Thr Cys
Gly Leu Cys Thr
Gly Leu Thr Cys
Gly Met Ser Val
Gly Met Val Ser
Gly Pro Gly Tyr
Gly Pro Tyr Gly
Gly Ser Met Val
Gly Ser Val Met
Gly Thr Cys Ile
Gly Thr Cys Leu
Gly Thr Ile Cys
Gly Thr Leu Cys
Gly Val Met Ser
Gly Val Ser Met
Gly Tyr Gly Pro
Gly Tyr Pro Gly
Ile Ala Cys Ser
Ile Ala Ser Cys
Ile Cys Ala Ser
Ile Cys Gly Thr
Ile Cys Ser Ala
Ile Cys Thr Gly
Ile Gly Cys Thr
Ile Gly Thr Cys
Ile Ser Ala Cys
Ile Ser Cys Ala
Ile Thr Cys Gly
Ile Thr Gly Cys
Leu Ala Cys Ser
Leu Ala Ser Cys
Leu Cys Ala Ser
Leu Cys Gly Thr
Leu Cys Ser Ala
Leu Cys Thr Gly
Leu Gly Cys Thr
Leu Gly Thr Cys
Leu Ser Ala Cys
Leu Ser Cys Ala
Leu Thr Cys Gly
Leu Thr Gly Cys
Met Ala Ala Thr
Met Ala Thr Ala
Met Gly Ser Val
Met Gly Val Ser
Met Ser Gly Val
Met Ser Val Gly
Met Thr Ala Ala
Met Val Gly Ser
Met Val Ser Gly
Pro Gly Gly Tyr
Pro Gly Tyr Gly
Pro Tyr Gly Gly
Ser Ala Cys Ile
Ser Ala Cys Leu
Ser Ala Ile Cys
Ser Ala Leu Cys
Ser Cys Ala Ile
Ser Cys Ala Leu
Ser Cys Ile Ala
Ser Cys Leu Ala
Ser Gly Met Val
Ser Gly Val Met
Ser Ile Ala Cys
Ser Ile Cys Ala
Ser Leu Ala Cys
Ser Leu Cys Ala
Ser Met Gly Val
Ser Met Val Gly
Ser Val Gly Met
Ser Val Met Gly
Thr Ala Ala Met
Thr Ala Cys Val
Thr Ala Met Ala
Thr Ala Val Cys
Thr Cys Ala Val
Thr Cys Gly Ile
Thr Cys Gly Leu
Thr Cys Ile Gly
Thr Cys Leu Gly
Thr Cys Val Ala
Thr Gly Cys Ile
Thr Gly Cys Leu
Thr Gly Ile Cys
Thr Gly Leu Cys
Thr Ile Cys Gly
Thr Ile Gly Cys
Thr Leu Cys Gly
Thr Leu Gly Cys
Thr Met Ala Ala
Thr Val Ala Cys
Thr Val Cys Ala
Val Ala Cys Thr
Val Ala Thr Cys
Val Cys Ala Thr
Val Cys Thr Ala
Val Gly Met Ser
Val Gly Ser Met
Val Met Gly Ser
Val Met Ser Gly
Val Ser Gly Met
Val Ser Met Gly
Val Thr Ala Cys
Val Thr Cys Ala
Tyr Gly Gly Pro
Tyr Gly Pro Gly
Tyr Pro Gly Gly
5-(tert-butyldiphenylsilyloxy)-1,3-benzenedimethanol
2,3-BIS(4-ETHYLPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
2-(9-Oxoxanthen-2-yl)propionic Acid 1,5-Diazabicyclo[4.3.0]non-5-ene Salt
4-{4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZIN-1-YL}BENZALDEHYDE
(S)-Methyl 2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoate
4-[2-[5,5-Dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid
12H-Isoquino[1,2-b]pyrrolo[3,2-f][1,3]benzoxazine-1-carboxylic acid, 3,6a,11,14-tetrahydro-9-methoxy-2-methyl-, ethyl ester
PD 102807 is a M4 muscarinic receptor antagonist with an IC50 of 90.7 nM. PD 102807 inhibits M1, M2, M3, M5 muscarinic receptor with IC50s of 6558.7, 3440.7, 950.0, and 7411.7 nM, respectively[1]. Antidyskinetic effect.
N-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-4-methoxy-2,3,6-trimethylbenzenesulfonamide
2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline
Mardepodect
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor